Citizens Financial Group Inc. RI Purchases 17,727 Shares of The Procter & Gamble Company (NYSE:PG)

Citizens Financial Group Inc. RI lifted its stake in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 3.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 582,814 shares of the company's stock after purchasing an additional 17,727 shares during the quarter. Procter & Gamble comprises approximately 2.0% of Citizens Financial Group Inc. RI's portfolio, making the stock its 10th biggest position. Citizens Financial Group Inc. RI's holdings in Procter & Gamble were worth $100,943,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Itau Unibanco Holding S.A. acquired a new stake in Procter & Gamble during the second quarter valued at approximately $28,000. Fairway Wealth LLC acquired a new stake in shares of Procter & Gamble in the second quarter worth $29,000. POM Investment Strategies LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at $34,000. Quest Partners LLC acquired a new position in shares of Procter & Gamble during the 2nd quarter worth $36,000. Finally, Fairfield Financial Advisors LTD bought a new stake in Procter & Gamble during the second quarter worth approximately $44,000. Institutional investors and hedge funds own 65.77% of the company's stock.

Procter & Gamble Price Performance

Shares of NYSE PG traded up $1.75 during midday trading on Thursday, reaching $172.64. 2,022,281 shares of the company traded hands, compared to its average volume of 6,653,676. The firm has a market cap of $406.57 billion, a PE ratio of 29.73, a PEG ratio of 3.69 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock's 50-day simple moving average is $170.01 and its 200-day simple moving average is $168.51. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $177.94.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts' consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm's revenue was down .6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.83 EPS. As a group, equities analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.33%. Procter & Gamble's payout ratio is 69.48%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on PG shares. Royal Bank of Canada restated a "sector perform" rating and issued a $164.00 price objective on shares of Procter & Gamble in a research note on Monday, October 21st. Piper Sandler began coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They issued a "neutral" rating and a $174.00 target price for the company. DA Davidson restated a "neutral" rating and issued a $160.00 price target on shares of Procter & Gamble in a report on Wednesday. Dbs Bank cut shares of Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 1st. Finally, StockNews.com lowered shares of Procter & Gamble from a "buy" rating to a "hold" rating in a research note on Thursday, August 1st. Nine analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $177.00.

Insider Buying and Selling at Procter & Gamble

In related news, insider Balaji Purushothaman sold 12,800 shares of the firm's stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the transaction, the insider now directly owns 11,566 shares of the company's stock, valued at approximately $1,954,538.34. This trade represents a 52.53 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jon R. Moeller sold 87,979 shares of the firm's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.40, for a total value of $14,991,621.60. Following the transaction, the chief executive officer now owns 300,777 shares of the company's stock, valued at approximately $51,252,400.80. The trade was a 22.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 174,727 shares of company stock worth $29,694,037 in the last quarter. 0.18% of the stock is currently owned by company insiders.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.